Water Drinking Test in Patients With Occludable Angle

Sponsor
Wills Eye (Other)
Overall Status
Completed
CT.gov ID
NCT02613533
Collaborator
(none)
20
1
1
59
0.3

Study Details

Study Description

Brief Summary

The water drinking test (WDT), is a predictive test that has been used to detect primary open angle glaucoma and recently has been demonstrated as a predictor of the diurnal tension curve. Clinically accurate provocative tests for asymptomatic eyes with shallow anterior chambers and narrow angles are highly desirable to detect patients prone to angle closure glaucoma. The aim of this pilot study is to evaluate the possible role of water drinking test in patients with narrow angles who are scheduled for prophylactic laser iridotomy.

Condition or Disease Intervention/Treatment Phase
  • Other: Intra-ocular pressure measurement (IOP)
N/A

Detailed Description

This prospective case series will investigate the effects of the WDT on subjects with narrow anterior chamber angles on the day of their scheduled laser iridotomy. The angle configuration and IOP will be monitored following the WDT. Twenty patients with occludable angles will be enrolled in this study. After measuring the baseline IOP, weight and height, the patients will be asked to drink 10ml/kg water over 15 minutes (equal to approximately 0.33 ounces of water for every 2.2 pounds of weight or 2 ½ cups for a 150 lb. individual) and their IOP will be checked every 15 minutes up to one hour after drinking the water. This will be repeated after performing a laser iridotomy. The data obtained, mainly IOP and gonioscopic findings, will be analyzed using statistical tests and compared to historical controls of the WDT without narrow angles, and laser iridotomy subjects without the WDT.

Study Design

Study Type:
Interventional
Actual Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
What is the Effect of the "Water Drinking Test" on Patients With Narrow Angles on the Day of Their Scheduled Laser Iridotomy?
Study Start Date :
Feb 1, 2010
Actual Primary Completion Date :
Jan 1, 2015
Actual Study Completion Date :
Jan 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Narrow Angle Glaucoma Study Group

Subjects will be given 10ml/kg of water over 15 min prior to surgery and Intra-ocular pressure measurement (IOP) is checked every 15 min before and after surgical procedure.

Other: Intra-ocular pressure measurement (IOP)
Subjects will be given 10ml/kg of water over 15 min prior to laser peripheral iridotomy (LPI) surgery and Intra-ocular pressure (IOP) is tested every 15 min before and after surgical procedure

Outcome Measures

Primary Outcome Measures

  1. Intra-ocular pressure measurement [every 15 minutes before and after surgery for upto an hour]

    Twenty patients with occludable angles will be enrolled in this study. After measuring the baseline Intra-ocular pressure, weight and height, the patients will be asked to drink 10ml/kg water over 15 minutes (equal to approximately 2 ½ cups for a 150 lb. individual) and their intra-ocular pressure (IOP) will be checked every 15 minutes up to one hour after drinking the water. This will be repeated after performing a laser peripheral iridotomy (LPI). The data obtained, mainly Intra-ocular pressure will be analyzed using statistical tests and compared to historical controls of the WDT without narrow angles, and laser iridotomy subjects without the WDT.

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • narrow angle judged to be at risk of attack by the treating physician, with one or more quadrants not open to the sclera spur on gonioscopy

  • age between 21 and 90 years

  • ability to give informed consent.

Exclusion Criteria:
  • baseline IOP higher than 21 mm Hg with or without medication

  • other causes of glaucoma, such as pseudoexfoliative and pigmentary glaucomas

  • previous treatment with argon laser or selective laser trabeculoplasty

  • previous refractive sugary; (5) pregnant women; (6) congestive heart failure

  • renal failure or urinary retention issues; (8) corneal abnormalities preventing reliable IOP measurement

  • non-glaucomatous optic neuropathy

  • prior refractive surgery or other issues preventing accurate Goldmann applanation tonometry

  • prior intraocular surgery

Contacts and Locations

Locations

Site City State Country Postal Code
1 Wills Eye Institute Philadelphia Pennsylvania United States 19107

Sponsors and Collaborators

  • Wills Eye

Investigators

  • Principal Investigator: Jonathan Myers, MD, Wills Eye

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jonathon Myers, Principle Investigator, Wills Eye
ClinicalTrials.gov Identifier:
NCT02613533
Other Study ID Numbers:
  • 10-988E
First Posted:
Nov 24, 2015
Last Update Posted:
Nov 30, 2017
Last Verified:
Nov 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 30, 2017